Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered question first ministerially corrected answering member label previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1128437

registered interest
date	23/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether (a) NICE and (b) NHS England take into account the availability of medicines under the Early Access to Medicines Scheme when assessing those same medicines for approval as new medicines.
tabling member constituency	Bolton West
tabling member printed	Chris Green
uin	257759
answer	answer is ministerial correction date of answer 07/06/2019 answer text <p>The National Institute for Health and Care Excellence takes into account the availability of medicines through the Early Access to Medicines Scheme (EAMS) in terms of scheduling its assessments, however the process followed in assessing the technology is the same as for non-EAMS technologies.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 07/06/2019 14:54:05 answering member 4455 label Biography information for Seema Kennedy
tabling member	4398 label Biography information for Chris Green

1128441

registered interest
date	23/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cannabis: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the accuracy of evidence base on the cost-effectiveness of medical cannabis.
tabling member constituency	Hemel Hempstead
tabling member printed	Sir Mike Penning
uin	257705
answer	answer is ministerial correction date of answer 10/06/2019 answer text <p>An initial impact assessment was published alongside The Misuse of Drugs (Amendments) (Cannabis and Licence Fees) (England, Wales and Scotland) Regulations 2018. This can be viewed at the following link:</p><p><a href="http://www.legislation.gov.uk/uksi/2018/1055/impacts" target="_blank">http://www.legislation.gov.uk/uksi/2018/1055/impacts</a></p><p>This set out the approach that the Government proposed to take in assessing the costs and benefits of the change in the law at a population level, with regard to the rescheduling of cannabis-based products for medicinal use (CBPM). This framework included potential savings in treatment costs, giving the example of patients with severe epilepsy for whom medicinal use of cannabis could reduce the frequency of seizures and reduce the number of related hospital admissions. This was an initial framework for assessing this policy and as we develop our knowledge in this area, both on the costs and the potential benefits, we can revisit and refine these assessments.</p><p>In the meantime, the National Institute for Health and Care Excellence (NICE) is developing clinical guidelines on the appropriate use of CBPM based on the best available evidence, and the National Institute for Health Research is funding further clinical research on this. More information is available at the following link:</p><p><a href="https://www.nihr.ac.uk/funding-and-support/documents/themed-calls/cannabis-based%20products/cannabis-based-products-brief.pdf" target="_blank">https://www.nihr.ac.uk/funding-and-support/documents/themed-calls/cannabis-based%20products/cannabis-based-products-brief.pdf</a></p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 10/06/2019 13:23:02 answering member 4455 label Biography information for Seema Kennedy
tabling member	1528 label Biography information for Sir Mike Penning

1128442

registered interest
date	23/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cannabis: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will publish the evidence (a) his Department and (b) the Department for International Trade holds on growing a market for prescribed medicinal cannabis.
tabling member constituency	Hemel Hempstead
tabling member printed	Sir Mike Penning
uin	257706
answer	answer is ministerial correction date of answer 10/06/2019 answer text <p><ins class="ministerial"> <p><ins class="ministerial">The Department for International Trade and the Department of Health and Social Care are not specifically collecting data on the growth of the market for cannabis based products for medicinal use in the United Kingdom.</ins></p><p><ins class="ministerial">However, data from the Medicines and Healthcare products Regulatory Agency (MHRA) shows growing numbers of import notifications for medicinal cannabis and the Home Office has received increased numbers of licence applications.</ins></p><p><ins class="ministerial">In addition, UK companies exporting these products and foreign companies looking to invest in the UK have full access to government support, where they have the necessary authorisations from the MHRA and Home Office and a relevant Export Licence.</ins></p></ins></p><p><del class="ministerial">An initial impact assessment was published alongside The Misuse of Drugs (Amendments) (Cannabis and Licence Fees) (England, Wales and Scotland) Regulations 2018. This can be viewed at the following link:</del></p><p><del class="ministerial"><a href="http://www.legislation.gov.uk/uksi/2018/1055/impacts" target="_blank">http://www.legislation.gov.uk/uksi/2018/1055/impacts</a></del></p><p><del class="ministerial">This set out the approach that the Government proposed to take in assessing the costs and benefits of the change in the law at a population level, with regard to the rescheduling of cannabis-based products for medicinal use (CBPM). This framework included potential savings in treatment costs, giving the example of patients with severe epilepsy for whom medicinal use of cannabis could reduce the frequency of seizures and reduce the number of related hospital admissions. This was an initial framework for assessing this policy and as we develop our knowledge in this area, both on the costs and the potential benefits, we can revisit and refine these assessments.</del></p><p><del class="ministerial">In the meantime, the National Institute for Health and Care Excellence (NICE) is developing clinical guidelines on the appropriate use of CBPM based on the best available evidence, and the National Institute for Health Research is funding further clinical research on this. More information is available at the following link:</del></p><p><del class="ministerial"><a href="https://www.nihr.ac.uk/funding-and-support/documents/themed-calls/cannabis-based%20products/cannabis-based-products-brief.pdf" target="_blank">https://www.nihr.ac.uk/funding-and-support/documents/themed-calls/cannabis-based%20products/cannabis-based-products-brief.pdf</a></del></p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 10/06/2019 13:18:03 question first ministerially corrected 11/06/2019 11:31:21 answering member 4455 label Biography information for Seema Kennedy previous answer version 121340 answering member constituency South Ribble answering member printed Seema Kennedy answering member 4455 label Biography information for Seema Kennedy
tabling member	1528 label Biography information for Sir Mike Penning

1128443

registered interest
date	23/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cannabis: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, when he plans to publish the interim report produced by NHS England to identify the barriers that are blocking access to prescribed medicinal cannabis by patients.
tabling member constituency	Hemel Hempstead
tabling member printed	Sir Mike Penning
uin	257707
answer	answer is ministerial correction date of answer 07/06/2019 answer text <p>The NHS England process review is underway and interviews are scheduled to take place over June 2019. The interim report will not be published, as by its nature any findings will be incomplete. The Government is, however, committed to publishing a summary of the final findings and recommendations before summer recess.</p><p> </p><p> </p><p><strong> </strong></p><p><strong> </strong></p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 257708 question first answered 07/06/2019 14:49:30 answering member 4455 label Biography information for Seema Kennedy
tabling member	1528 label Biography information for Sir Mike Penning

1128444

registered interest
date	23/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cannabis: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, when he plans to publish the final report by NHS England to identify the barriers that are blocking access to prescribed medicinal cannabis by patients.
tabling member constituency	Hemel Hempstead
tabling member printed	Sir Mike Penning
uin	257708
answer	answer is ministerial correction date of answer 07/06/2019 answer text <p>The NHS England process review is underway and interviews are scheduled to take place over June 2019. The interim report will not be published, as by its nature any findings will be incomplete. The Government is, however, committed to publishing a summary of the final findings and recommendations before summer recess.</p><p> </p><p> </p><p><strong> </strong></p><p><strong> </strong></p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 257707 question first answered 07/06/2019 14:49:30 answering member 4455 label Biography information for Seema Kennedy
tabling member	1528 label Biography information for Sir Mike Penning

1128455

registered interest
date	23/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Care Homes: Inspections
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what recent assessment he has made on the effectiveness of inspection methods in care homes.
tabling member constituency	Great Grimsby
tabling member printed	Melanie Onn
uin	257773
answer	answer is ministerial correction date of answer 10/06/2019 answer text <p>The Care Quality Commission (CQC) is the independent regulator of health and adult social care providers in England and has a key responsibility in the overall assurance of safety and quality of health and adult social care services. The CQC monitors its own effectiveness of inspection methods in care home and other health settings in a number of ways to ensure that everyone is safe from harm, abuse and neglect. In addition, the CQC is currently collaborating with the University of Manchester’s Alliance Manchester Business School on research exploring the impact of the CQC on the quality of care.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 10/06/2019 15:18:33 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	4464 label Biography information for Melanie Onn

1128461

registered interest
date	23/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Plastic Surgery: Lancashire
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many corrective medical procedures were carried out by (a) Lancashire Teaching Hospitals, (b) University Hospitals of Morecambe Bay, (c) Blackpool Teaching Hospitals to (i) rectify and (ii) treat complications following privately paid for cosmetic procedures; and what the cost was to the NHS of (A) those corrective procedures and (B) associated care.
tabling member constituency	Preston
tabling member printed	Sir Mark Hendrick
uin	257653
answer	answer is ministerial correction date of answer 07/06/2019 answer text <p>The information requested on corrective medical procedures is not collected centrally.</p> answering member constituency Wimbledon answering member printed Stephen Hammond question first answered 07/06/2019 13:05:08 answering member 1585 label Biography information for Stephen Hammond
tabling member	473 label Biography information for Sir Mark Hendrick

1128462

registered interest
date	23/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Social Services: Older People
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what (a) funding and (b) grants her Department makes available to elderly people in relation to the provision of social care.
tabling member constituency	North Cornwall
tabling member printed	Scott Mann
uin	257783
answer	answer is ministerial correction date of answer 10/06/2019 answer text <p>The Government has given councils access to up to £3.9 billion for 2019-20. This includes a £240 million adult social care winter fund to help local authorities alleviate winter pressures on the National Health Service, getting patients home quicker and freeing up hospital beds across England. As a result of these measures, funding available for adult social care is increasing by 9% in real terms from 2015-16 to 2019-20, allowing councils to support more people including the elderly and to sustain a diverse care market.</p><p>The Disabled Facilities Grant supports older and disabled people, on low incomes, to adapt their homes to make them suitable for their needs. The amount of funding available has more than doubled from £220 million in 2015-16 to £505 million in 2019-20.</p><p> </p><p>Furthermore, the most recent data shows public spending figures on adult social care amounted to £17.1 billion in 2017-18 with £5.3 billion spent on older adults.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 10/06/2019 15:39:43 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	4496 label Biography information for Scott Mann

1128505

registered interest
date	23/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Primary Care Networks: General Practitioners
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether safeguards are in place to ensure that patients' rights to continuity of care with their named GP will be protected in the new Primary Care Network contract, published in March 2019.
tabling member constituency	Colne Valley
tabling member printed	Thelma Walker
uin	257814
answer	answer is ministerial correction date of answer 10/06/2019 answer text <p>The new Primary Care Network arrangements will not prevent patients seeing their preferred professional at their practice. The core general practice contract will still include a requirement for each contractor to ensure that for each of its registered patients, there is assigned an accountable general medical practitioner (an ‘accountable GP’).</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 10/06/2019 15:24:15 answering member 4455 label Biography information for Seema Kennedy
tabling member	4649 label Biography information for Thelma Walker

1128513

registered interest
date	23/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Organs: Donors
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to encourage organ donation in BAME communities.
tabling member constituency	Hackney South and Shoreditch
tabling member printed	Meg Hillier
uin	257701
answer	answer is ministerial correction date of answer 07/06/2019 answer text <p>Shortages of organs for transplant are relevant to people from all backgrounds but are particularly acute for black, Asian and minority ethnic (BAME) patients, who are more likely to need an organ transplant. The Department launched a campaign in July 2018, delivered by NHS Blood and Transplant, with support from the National Black, Asian, and Minority Ethnic Transplant Alliance, to increase donation rates by raising awareness and breaking down barriers to donation within these communities. A toolkit for hon. Members is available at the following link:</p><p><a href="http://bit.ly/bameODtoolkit" target="_blank">http://bit.ly/bameODtoolkit</a></p><p>As part of the campaign, funding was made available for a community investment scheme and in January 2019, 25 projects were successful in sharing £140,000 in funding to break down myths and barriers and increase support for organ donation among BAME communities. Organisations representing Jain, Sikh, Hindu, Muslim, Swahili, black and Asian Christians, black African and Caribbean and multi-faith groups received funding for their projects.</p><p>In addition, the Organ Donation (Deemed Consent Act) 2019 will be introducing a new system of consent for organ and tissue donation in England, from 2020, to help increase the number of donors. In April, NHS Blood and Transplant launched a 12-month communication campaign before the law comes into force, to raise awareness of the changes and the options available under the new system. The campaign will target BAME communities and campaign materials have been developed to resonate with different audiences and communities. NHS Blood and Transplant also plans to translate the leaflet containing details of the new law into different languages. NHS Blood and Transplant will be seeking the support of various BAME communities and faith and belief organisations to spread the campaign message.</p><p>From 2020, health education will become compulsory in all state-funded primary and secondary schools. This will include the teaching of the science relating to blood, organ and stem cell donation.</p><p> </p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 07/06/2019 13:18:57 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	1524 label Biography information for Dame Meg Hillier